Global Gastroparesis Drugs Market Insights and Forecast to 2028

Global Gastroparesis Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Gastroparesis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastroparesis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastroparesis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastroparesis Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Gastroparesis Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Gastroparesis Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gastroparesis Drugs Sales by Region
2.4.1 Global Gastroparesis Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Gastroparesis Drugs by Region (2023-2028)
2.5 Global Gastroparesis Drugs Revenue by Region
2.5.1 Global Gastroparesis Drugs Revenue by Region (2017-2022)
2.5.2 Global Gastroparesis Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gastroparesis Drugs Sales by Manufacturers
3.1.1 Global Top Gastroparesis Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Gastroparesis Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastroparesis Drugs in 2021
3.2 Global Gastroparesis Drugs Revenue by Manufacturers
3.2.1 Global Gastroparesis Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gastroparesis Drugs Revenue in 2021
3.3 Global Gastroparesis Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gastroparesis Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gastroparesis Drugs Sales by Type
4.1.1 Global Gastroparesis Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Gastroparesis Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Gastroparesis Drugs Sales Market Share by Type (2017-2028)
4.2 Global Gastroparesis Drugs Revenue by Type
4.2.1 Global Gastroparesis Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Gastroparesis Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Gastroparesis Drugs Price by Type
4.3.1 Global Gastroparesis Drugs Price by Type (2017-2022)
4.3.2 Global Gastroparesis Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gastroparesis Drugs Sales by Application
5.1.1 Global Gastroparesis Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Gastroparesis Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Gastroparesis Drugs Sales Market Share by Application (2017-2028)
5.2 Global Gastroparesis Drugs Revenue by Application
5.2.1 Global Gastroparesis Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Gastroparesis Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Gastroparesis Drugs Price by Application
5.3.1 Global Gastroparesis Drugs Price by Application (2017-2022)
5.3.2 Global Gastroparesis Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gastroparesis Drugs Market Size by Type
6.1.1 North America Gastroparesis Drugs Sales by Type (2017-2028)
6.1.2 North America Gastroparesis Drugs Revenue by Type (2017-2028)
6.2 North America Gastroparesis Drugs Market Size by Application
6.2.1 North America Gastroparesis Drugs Sales by Application (2017-2028)
6.2.2 North America Gastroparesis Drugs Revenue by Application (2017-2028)
6.3 North America Gastroparesis Drugs Market Size by Country
6.3.1 North America Gastroparesis Drugs Sales by Country (2017-2028)
6.3.2 North America Gastroparesis Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gastroparesis Drugs Market Size by Type
7.1.1 Europe Gastroparesis Drugs Sales by Type (2017-2028)
7.1.2 Europe Gastroparesis Drugs Revenue by Type (2017-2028)
7.2 Europe Gastroparesis Drugs Market Size by Application
7.2.1 Europe Gastroparesis Drugs Sales by Application (2017-2028)
7.2.2 Europe Gastroparesis Drugs Revenue by Application (2017-2028)
7.3 Europe Gastroparesis Drugs Market Size by Country
7.3.1 Europe Gastroparesis Drugs Sales by Country (2017-2028)
7.3.2 Europe Gastroparesis Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastroparesis Drugs Market Size by Type
8.1.1 Asia Pacific Gastroparesis Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Gastroparesis Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Gastroparesis Drugs Market Size by Application
8.2.1 Asia Pacific Gastroparesis Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Gastroparesis Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Gastroparesis Drugs Market Size by Region
8.3.1 Asia Pacific Gastroparesis Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Gastroparesis Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Gastroparesis Drugs Market Size by Type
9.1.1 Latin America Gastroparesis Drugs Sales by Type (2017-2028)
9.1.2 Latin America Gastroparesis Drugs Revenue by Type (2017-2028)
9.2 Latin America Gastroparesis Drugs Market Size by Application
9.2.1 Latin America Gastroparesis Drugs Sales by Application (2017-2028)
9.2.2 Latin America Gastroparesis Drugs Revenue by Application (2017-2028)
9.3 Latin America Gastroparesis Drugs Market Size by Country
9.3.1 Latin America Gastroparesis Drugs Sales by Country (2017-2028)
9.3.2 Latin America Gastroparesis Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastroparesis Drugs Market Size by Type
10.1.1 Middle East and Africa Gastroparesis Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gastroparesis Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Gastroparesis Drugs Market Size by Application
10.2.1 Middle East and Africa Gastroparesis Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gastroparesis Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Gastroparesis Drugs Market Size by Country
10.3.1 Middle East and Africa Gastroparesis Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gastroparesis Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Corporation Information
11.1.2 Sumitomo Overview
11.1.3 Sumitomo Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sumitomo Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sumitomo Recent Developments
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Corporation Information
11.2.2 Cadila Pharmaceuticals Overview
11.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cadila Pharmaceuticals Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Kyowa Kirin Pharmaceuticals
11.7.1 Kyowa Kirin Pharmaceuticals Corporation Information
11.7.2 Kyowa Kirin Pharmaceuticals Overview
11.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kyowa Kirin Pharmaceuticals Recent Developments
11.8 Hanmi Pharm
11.8.1 Hanmi Pharm Corporation Information
11.8.2 Hanmi Pharm Overview
11.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hanmi Pharm Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hanmi Pharm Recent Developments
11.9 Ani Pharmaceuticals
11.9.1 Ani Pharmaceuticals Corporation Information
11.9.2 Ani Pharmaceuticals Overview
11.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ani Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gastroparesis Drugs Industry Chain Analysis
12.2 Gastroparesis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastroparesis Drugs Production Mode & Process
12.4 Gastroparesis Drugs Sales and Marketing
12.4.1 Gastroparesis Drugs Sales Channels
12.4.2 Gastroparesis Drugs Distributors
12.5 Gastroparesis Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gastroparesis Drugs Industry Trends
13.2 Gastroparesis Drugs Market Drivers
13.3 Gastroparesis Drugs Market Challenges
13.4 Gastroparesis Drugs Market Restraints
14 Key Findings in The Global Gastroparesis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Gastroparesis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Prokinetic Agents
Table 3. Major Manufacturers of Antiemetic Agents
Table 4. Major Manufacturers of Others
Table 5. Global Gastroparesis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Gastroparesis Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Gastroparesis Drugs Sales by Region (2017-2022) & (Kg)
Table 8. Global Gastroparesis Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Gastroparesis Drugs Sales by Region (2023-2028) & (Kg)
Table 10. Global Gastroparesis Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Gastroparesis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Gastroparesis Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Gastroparesis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Gastroparesis Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Gastroparesis Drugs Sales by Manufacturers (2017-2022) & (Kg)
Table 16. Global Gastroparesis Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Gastroparesis Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Gastroparesis Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Gastroparesis Drugs Price by Manufacturers (2017-2022) &(US$/mg)
Table 20. Global Gastroparesis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Drugs as of 2021)
Table 22. Gastroparesis Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Gastroparesis Drugs Product Offered
Table 24. Date of Manufacturers Enter into Gastroparesis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 27. Global Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 28. Global Gastroparesis Drugs Sales Share by Type (2017-2022)
Table 29. Global Gastroparesis Drugs Sales Share by Type (2023-2028)
Table 30. Global Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Gastroparesis Drugs Revenue Share by Type (2017-2022)
Table 33. Global Gastroparesis Drugs Revenue Share by Type (2023-2028)
Table 34. Gastroparesis Drugs Price by Type (2017-2022) & (US$/mg)
Table 35. Global Gastroparesis Drugs Price Forecast by Type (2023-2028) & (US$/mg)
Table 36. Global Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 37. Global Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 38. Global Gastroparesis Drugs Sales Share by Application (2017-2022)
Table 39. Global Gastroparesis Drugs Sales Share by Application (2023-2028)
Table 40. Global Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Gastroparesis Drugs Revenue Share by Application (2017-2022)
Table 43. Global Gastroparesis Drugs Revenue Share by Application (2023-2028)
Table 44. Gastroparesis Drugs Price by Application (2017-2022) & (US$/mg)
Table 45. Global Gastroparesis Drugs Price Forecast by Application (2023-2028) & (US$/mg)
Table 46. North America Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 47. North America Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 48. North America Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 51. North America Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 52. North America Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 55. North America Gastroparesis Drugs Sales by Country (2023-2028) & (Kg)
Table 56. North America Gastroparesis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Gastroparesis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 59. Europe Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 60. Europe Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 63. Europe Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 64. Europe Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 67. Europe Gastroparesis Drugs Sales by Country (2023-2028) & (Kg)
Table 68. Europe Gastroparesis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Gastroparesis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 71. Asia Pacific Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 72. Asia Pacific Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 75. Asia Pacific Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 76. Asia Pacific Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Gastroparesis Drugs Sales by Region (2017-2022) & (Kg)
Table 79. Asia Pacific Gastroparesis Drugs Sales by Region (2023-2028) & (Kg)
Table 80. Asia Pacific Gastroparesis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Gastroparesis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 83. Latin America Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 84. Latin America Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 87. Latin America Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 88. Latin America Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 91. Latin America Gastroparesis Drugs Sales by Country (2023-2028) & (Kg)
Table 92. Latin America Gastroparesis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Gastroparesis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 95. Middle East and Africa Gastroparesis Drugs Sales by Type (2023-2028) & (Kg)
Table 96. Middle East and Africa Gastroparesis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Gastroparesis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 99. Middle East and Africa Gastroparesis Drugs Sales by Application (2023-2028) & (Kg)
Table 100. Middle East and Africa Gastroparesis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Gastroparesis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 103. Middle East and Africa Gastroparesis Drugs Sales by Country (2023-2028) & (Kg)
Table 104. Middle East and Africa Gastroparesis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Gastroparesis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Sumitomo Corporation Information
Table 107. Sumitomo Description and Major Businesses
Table 108. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 109. Sumitomo Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Sumitomo Recent Developments
Table 111. Cadila Pharmaceuticals Corporation Information
Table 112. Cadila Pharmaceuticals Description and Major Businesses
Table 113. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 114. Cadila Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Cadila Pharmaceuticals Recent Developments
Table 116. Sanofi Corporation Information
Table 117. Sanofi Description and Major Businesses
Table 118. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 119. Sanofi Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Sanofi Recent Developments
Table 121. Teva Corporation Information
Table 122. Teva Description and Major Businesses
Table 123. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 124. Teva Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Teva Recent Developments
Table 126. Johnson & Johnson Corporation Information
Table 127. Johnson & Johnson Description and Major Businesses
Table 128. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 129. Johnson & Johnson Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Johnson & Johnson Recent Developments
Table 131. Pfizer Corporation Information
Table 132. Pfizer Description and Major Businesses
Table 133. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 134. Pfizer Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Pfizer Recent Developments
Table 136. Kyowa Kirin Pharmaceuticals Corporation Information
Table 137. Kyowa Kirin Pharmaceuticals Description and Major Businesses
Table 138. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 139. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Kyowa Kirin Pharmaceuticals Recent Developments
Table 141. Hanmi Pharm Corporation Information
Table 142. Hanmi Pharm Description and Major Businesses
Table 143. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 144. Hanmi Pharm Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Hanmi Pharm Recent Developments
Table 146. Ani Pharmaceuticals Corporation Information
Table 147. Ani Pharmaceuticals Description and Major Businesses
Table 148. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
Table 149. Ani Pharmaceuticals Gastroparesis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Ani Pharmaceuticals Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Gastroparesis Drugs Distributors List
Table 154. Gastroparesis Drugs Customers List
Table 155. Gastroparesis Drugs Market Trends
Table 156. Gastroparesis Drugs Market Drivers
Table 157. Gastroparesis Drugs Market Challenges
Table 158. Gastroparesis Drugs Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastroparesis Drugs Product Picture
Figure 3. Global Gastroparesis Drugs Market Share by Type in 2021 & 2028
Figure 3. Prokinetic Agents Product Picture
Figure 4. Antiemetic Agents Product Picture
Figure 5. Others Product Picture
Figure 6. Global Gastroparesis Drugs Market Share by Application in 2021 & 2028
Figure 7. Diabetic Gastroparesis
Figure 8. Idiopathic Gastroparesis
Figure 9. Gastroparesis Drugs Report Years Considered
Figure 10. Global Gastroparesis Drugs Sales 2017-2028 (Kg)
Figure 11. Global Gastroparesis Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Gastroparesis Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Gastroparesis Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Gastroparesis Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Gastroparesis Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Gastroparesis Drugs Sales YoY (2017-2028) & (Kg)
Figure 17. North America Gastroparesis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Gastroparesis Drugs Sales YoY (2017-2028) & (Kg)
Figure 19. Europe Gastroparesis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Gastroparesis Drugs Sales YoY (2017-2028) & (Kg)
Figure 21. Asia-Pacific Gastroparesis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Gastroparesis Drugs Sales YoY (2017-2028) & (Kg)
Figure 23. Latin America Gastroparesis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Gastroparesis Drugs Sales YoY (2017-2028) & (Kg)
Figure 25. Middle East & Africa Gastroparesis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Gastroparesis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Gastroparesis Drugs in the World: Market Share by Gastroparesis Drugs Revenue in 2021
Figure 28. Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Gastroparesis Drugs Sales Share by Country (2017-2028)
Figure 38. North America Gastroparesis Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Gastroparesis Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Gastroparesis Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Gastroparesis Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Gastroparesis Drugs Revenue Share by Region (2017-2028)
Figure 58. China Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Gastroparesis Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Gastroparesis Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Gastroparesis Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Gastroparesis Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Gastroparesis Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Gastroparesis Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Afric

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs